{"anticipatedPostingDate":"2027-01","denomUnitsSelected":"Participants","description":"Will be graded according to Common Terminology Criteria for Adverse Events version 5.0. Any eligible patient who receives at least one dose of protocol therapy will be considered in the evaluation of toxicity.","reportingStatus":"NOT_POSTED","timeFrame":"From enrollment to the end of treatment, up to 2 years","title":"Percentage of Patients Experiencing Grade 3 or 4 Adverse Events","type":"SECONDARY"}